JP Morgan expects STI at 5,000, supported by passive funds flow, lower interest rates and companies adopting value unlocking ...
CorMedix acquires Melinta, diversifies products, and raises 2025 revenue outlook to $375M. Read here for more details on CRMD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback